Come up with a name for your new list and we'll add to it:
Focal Point Pharmaceuticals raised a round of funding on January 31, 2017. Investors include
MB Venture Partners.
Focal Point Pharmaceuticals is an early stage company developing products for ocular diseases. The aim of the company is to provide new therapeutics for rare diseases that would be granted orphan stat…